Insights On Partnering

  1. The Immune System's Secret Language: Unlocking Cellular Communication 10/15/2025

    The rising rate of autoimmune conditions requires better ways to monitor cellular activity. See how profiling immune cells by their DNA signatures enables real-time therapeutic insight and prediction.

  2. The Shift Toward Flexible FSP Models 11/13/2025

    Flexible FSP models are reshaping clinical outsourcing by offering sponsors scalable, cost-predictable partnerships that preserve control, enhance quality, and support long-term strategic goals.

  3. Why Settle For Good Enough On The "Easy" Stuff? 10/8/2025

    High-stakes expertise shouldn’t be reserved for complex trials. Applying strategic support early helps prevent inefficiencies, delays, and missed opportunities.

  4. TPDs: Developing The Next Generation Of Oral Therapeutics 10/20/2025

    Targeted Protein Degraders are a revolutionary drug class with challenges in bioavailability and formulation complexity. Strategic CDMO partnerships are key to successful, scalable development.

  5. Paperless Online Remote Source Document Verification 2/2/2026

    Learn how Clinical Trial Organizations, Monitoring Teams and Clinical Sites can benefit from the way Judi transforms rSDV from a logistical hurdle into a strategic asset.

  6. Clinical Trial Payments And Ethics: Your Top Questions Answered 5/22/2025

    Fair compensation in trials requires distinguishing reimbursement from stipends. Learn the ethical principles that ensure payments uphold participant respect and remove financial barriers.

  7. Considerations For Drug-Device Combination Products In Rare Diseases 8/7/2025

    The development process for these products is complex, requiring careful consideration of regulatory requirements, technical feasibility, clinical efficacy, and patient-centered design.

  8. The Next Frontier In Early Phase Oncology Trials 10/18/2024

    This session explores the pivotal role of First-in-Human and early phase oncology trials in drug development, emphasizing the importance of comprehensive planning for successful execution.

  9. Dysfunctions Of Clinical Trial Vendor Selection And Overcoming Them 10/21/2025

    Vendor selection often fails due to five common dysfunctions. Identifying and addressing them early improves alignment, trust, and trial performance—avoiding costly delays.

  10. What ASCO 2025 Means For The Future Of Oncology Trials 6/13/2025

    Review the ASCO 2025 Annual Meeting, highlighting oncology trials and the need for agile, globally capable CRO partners to navigate today’s evolving trial landscape.